ArticleThe Journal of clinical investigation2016

BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models.

Yuki Kagoya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.